Stay updated on Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial

Sign up to get notified when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a formal study-reporting structure and status notes (Study Status, Outcome Measures, Participant Flow, etc.) with a conclusion pending date; no deletions observed.
    Difference
    2%
    Check dated 2025-10-13T11:49:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Updated operating-status notice and a new software version (v3.2.0) replacing the old v3.1.0; overall, the page now reflects current status and a newer release.
    Difference
    10%
    Check dated 2025-10-06T05:49:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.2%
    Check dated 2025-09-29T03:09:09.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated revision to v3.0.2 and removed the 'Back to Top' link.
    Difference
    0.6%
    Check dated 2025-09-14T19:21:48.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to version 3.0.1, with the addition of detailed study information and a new revision number, while the previous version 3.0.0 has been removed.
    Difference
    5%
    Check dated 2025-09-07T16:09:28.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.
    Difference
    37%
    Check dated 2025-08-31T11:55:53.000Z thumbnail image

Stay in the know with updates to Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.